Liraglutide Investigated for Reducing Epicardial Fat in Type 2 Diabetes Patients
Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
Abstract
A withdrawn study aimed to assess Liraglutide's effect on epicardial fat in Type 2 Diabetes patients, a common issue linked to poor glycemic control.